Sodium fluoride prevents bone loss in primary biliary cirrhosis
- 31 July 1992
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 15 (3) , 345-349
- https://doi.org/10.1016/0168-8278(92)90066-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Fluoride and vertebral fracturesThe Lancet, 1990
- Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 1990
- Fluoride Therapy for the Vertebral Crush Fracture SyndromeAnnals of Internal Medicine, 1989
- RISK-BENEFIT RATIO OF SODIUM FLUORIDE TREATMENT IN PRIMARY VERTEBRAL OSTEOPOROSISThe Lancet, 1988
- Metabolic bone disease in primary biliary cirrhosis at presentationGastroenterology, 1988
- Low bone turnover state in primary biliary cirrhosisHepatology, 1987
- Bone Loss and Reduced Osteoblast Function in Primary Biliary CirrhosisAnnals of Internal Medicine, 1985
- Bone Disease in Primary Biliary Cirrhosis: Increased Bone Resorption and Turnover in the Absence of Osteoporosis or OsteomalaciaHepatology, 1984
- New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease.Journal of Clinical Investigation, 1980
- INTESTINAL ABSORPTION OF 25-HYDROXYVITAMIN D AND OSTEOMALACIA IN PRIMARY BILIARY CIRRHOSISThe Lancet, 1977